Literature DB >> 23884858

COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.

Akihiro Yoshida1, Jun-Ya Kato, Ikuko Nakamae, Noriko Yoneda-Kato.   

Abstract

The ubiquitin ligase constitutively photomorphogenic 1 (COP1) is involved in many biological responses in mammalian cells, but its role in tumorigenesis remains unclear. Here we show that COP1 is a ubiquitin ligase for the tumor suppressor CCAAT/enhancer-binding protein (C/EBPα) and promotes its degradation in vivo, thereby blocking myeloid differentiation of hematopoietic cells for tumorigenesis. In this process, mammalian homolog of Tribbles, Trib1, which contains a COP1-binding motif, is essential for down-regulation of C/EBPα expression. Murine bone marrow transplantation experiments showed that coexpression of COP1 accelerates development of acute myeloid leukemia induced by Trib1, which pathologically resembles that of p42C/EBPα-deficient mice. Interestingly, coexpression of ligase activity-deficient COP1 mutant abrogated Trib1-induced leukemogenesis. These results indicate that COP1 and Trib1 act as an oncoprotein complex functioning upstream of C/EBPα, and its ligase activity is crucial for leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884858     DOI: 10.1182/blood-2012-12-476101

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  The pseudokinase TRIB1 toggles an intramolecular switch to regulate COP1 nuclear export.

Authors:  Jennifer E Kung; Natalia Jura
Journal:  EMBO J       Date:  2019-01-28       Impact factor: 11.598

2.  Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.

Authors:  Ikuko Nakamae; Jun-Ya Kato; Takashi Yokoyama; Hidenori Ito; Noriko Yoneda-Kato
Journal:  Blood Adv       Date:  2017-09-01

Review 3.  From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease.

Authors:  Sylvia T Nurnberg; Hanrui Zhang; Nicholas J Hand; Robert C Bauer; Danish Saleheen; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

Review 4.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

5.  E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.

Authors:  Yan Zhang; Shigetoshi Yokoyama; John C Herriges; Zhen Zhang; Randee E Young; Jamie M Verheyden; Xin Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-22       Impact factor: 11.205

6.  Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1.

Authors:  Sam A Jamieson; Zheng Ruan; Abigail E Burgess; Jack R Curry; Hamish D McMillan; Jodi L Brewster; Anita K Dunbier; Alison D Axtman; Natarajan Kannan; Peter D Mace
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

7.  Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages.

Authors:  Lilli Arndt; Janine Dokas; Martin Gericke; Carl Elias Kutzner; Silvana Müller; Franziska Jeromin; Joachim Thiery; Ralph Burkhardt
Journal:  J Biol Chem       Date:  2018-06-13       Impact factor: 5.157

8.  Tribbles-1 regulates hepatic lipogenesis through posttranscriptional regulation of C/EBPα.

Authors:  Robert C Bauer; Makoto Sasaki; Daniel M Cohen; Jian Cui; Mikhaila A Smith; Batuhan O Yenilmez; David J Steger; Daniel J Rader
Journal:  J Clin Invest       Date:  2015-09-08       Impact factor: 14.808

Review 9.  Transcription factor and cytokine regulation of eosinophil lineage commitment.

Authors:  Ethan A Mack; Warren S Pear
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.218

Review 10.  The Critical Role of TRIB2 in Cancer and Therapy Resistance.

Authors:  Victor Mayoral-Varo; Lucía Jiménez; Wolfgang Link
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.